The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.
about
Allergen injection immunotherapy for seasonal allergic rhinitisNovel developments in the mechanisms of immune tolerance to allergensMeasurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy)Serum levels of eosinophil cationic protein and eosinophils in asthmatic children during a course of prednisolone therapy.Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice.Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.Biologic rhythms in the immune system.Immunotherapy in asthma: an updated systematic review.Mechanisms of allergen-specific immunotherapy.Airway hyperresponsiveness. Relevance of random population data to clinical usefulness.Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.Mechanisms of interleukin-10-mediated immune suppression.Clinical practice guideline: Allergic rhinitis.Systemic reactions to allergen immunotherapy: a review of the literature.Recent advances in asthma.Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.Actual therapeutic management of allergic and hyperreactive nasal disordersDemonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.Advances in specific immunotherapy.Advances in allergen-specific immunotherapy.Targets in allergy-directed immunotherapy.Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.Allergen-specific immunotherapy in food anaphylaxis.Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.The effect of rush immunotherapy with house dust mite in the production of IL-5 and IFN-gamma from the peripheral blood T cells of asthmatic children.Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.Current understanding of the role of the eosinophil granulocyte in asthma.Role of interleukin 10 in specific immunotherapy.Definition and assessment of asthma.Immunological mechanisms of allergen-specific immunotherapy.What is the role of the eosinophil?Immunotherapy in all aspects.Immunotherapy for allergic rhinitis.Defining the T cell antigen proteome of wasp venom.Grass pollen immunotherapy decreases the number of mast cells in the skin.Nonspecific bronchial hyperresponsiveness and development of asthma in children with hay fever.Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.Soluble markers of allergic inflammation.Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma.The role of eosinophils in the pathogenesis of atopic dermatitis--eosinophil granule proteins as markers of disease activity.
P2860
Q24243115-2D9F4C2D-D853-4697-935F-FFB557825B97Q27025655-945D6EBA-3973-437D-95E9-A917F6A76085Q28288938-B35B1A5C-2683-4AC5-8748-3F8618DAFF44Q31950496-A6A1C2CD-B2C3-484C-B5C0-62E9FCF6CF68Q33631973-FA0DA78F-6CF9-4E5C-8AB0-E3B7FC69D4ABQ33737248-36513051-CCC0-427A-88A9-1CE450D3685CQ33747939-C64D4969-60C1-402B-B673-7A867BAD8CA5Q33760677-645FEE8E-6631-40DE-AE8C-EF732CAC4934Q33945896-0FB490FD-7855-4A3F-99E0-A9C4042590A8Q34055702-7D520993-88A1-4FD0-966D-A46975147999Q34170327-BAEDF8F1-2103-4539-87F5-9C29738209D1Q34285968-09E109F7-4937-4DA1-BF8F-9E86A9AF8473Q34460983-269D124D-4E4B-40C7-A45B-AACCAC4AFEEFQ35098554-4A86D0D3-770C-4A4B-A000-B0EBD9EA8ABAQ35277314-74CA1203-16AE-4F41-BC93-27D2C0A80AE8Q35298118-5C394140-788B-4AAF-AF7B-FF225807A292Q35427205-B44DD628-AB6E-4EA2-A67F-1549713CF4E7Q35532759-13AD2635-6B4D-4BF6-B035-21F051FE0875Q35593854-F505516F-BAEE-48E5-B0E9-494CD625FB0CQ36150445-5E8D804A-706C-4CA9-8F25-0E057C432E0CQ36150810-FBBC3BAC-C314-4D02-B68A-B1B600478C93Q36515366-BFAE7A49-8BD1-41A5-BBD2-45400F33E150Q36834317-812EBF14-7493-4137-893E-6E6AE73EDF8CQ37204677-58C12248-CDC2-4BB1-AB81-2FFDD204D427Q37232011-5A008849-8E40-4305-9327-9030CF87B04DQ37360604-65E535B1-E732-43D6-9A02-DAA858558F64Q37365387-8FCEF915-7BE9-4E6E-8FFB-4256375F1BF9Q37387064-58133530-8EC5-4149-9EF8-8E3A100B8CAEQ37822423-AAC84ACC-90E4-45D5-ACCC-D3A41392E997Q37861875-52474810-CB75-4732-B884-BC9994BA784FQ37918423-45094170-E81F-405B-AEE4-D5205D6BA23CQ38352179-84AF5255-5AC1-4111-9BF0-88E34D426E57Q39260807-BC69FBA7-F541-43BD-B060-32933CB220FCQ40282948-D4D06156-D7B9-467A-9724-4BE760C689AFQ40631611-0703694C-F002-4C69-BD81-9D4FD6AB2049Q40677823-0AF4C4EA-CC42-4753-A0DC-7A67EF860BDCQ40758775-FCB5242A-0FCE-469C-9E77-2D7446F2EA45Q40759554-AF2B2802-96A9-4138-BD1A-F28AA843DBDBQ40842566-C4B695F9-24AF-468D-A52D-1621CEB6F3DBQ40888911-B3979662-D2B4-4F7F-91C2-36B132A3AD9B
P2860
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
The effect of immunotherapy on ...... n in pollen-allergic patients.
@en
The effect of immunotherapy on ...... n in pollen-allergic patients.
@nl
type
label
The effect of immunotherapy on ...... n in pollen-allergic patients.
@en
The effect of immunotherapy on ...... n in pollen-allergic patients.
@nl
prefLabel
The effect of immunotherapy on ...... n in pollen-allergic patients.
@en
The effect of immunotherapy on ...... n in pollen-allergic patients.
@nl
P2093
P921
P1476
The effect of immunotherapy on ...... n in pollen-allergic patients.
@en
P2093
P304
P356
10.1016/0091-6749(88)90021-8
P407
P433
P577
1988-09-01T00:00:00Z